Pharmaceutical Analysis & Statistics in Netherlands, December 2014

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

Publishers

  • All
    • Business Monitor International

All regions

data types

You might be interested in: Therapeutics, Drug, Cancer, more »

1-24 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: The Netherlands boasts a well-developed healthcare system and also an advanced pharmaceutical market, which has attracted significant domestic and foreign investment over the years. Demographic ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: The Netherlands has a well established pharmaceutical market with strength in vaccines and biologics. As a result, the country has the necessary infrastructure and skilled workforce to be regarded ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country’s modest per capita expenditure on pharmaceuticals ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country’s modest per capita expenditure on pharmaceuticals relative to other Western Europe ...

  • Industries : Drug and Medication
  • Countries : Netherlands



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.